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| INTRODUC TI ON
Colorectal cancer (CRC) is the third most common malignance and is one leading cause of cancer-related deaths in the world. 1 Despite great efforts that have been made to understand the pathogenesis of CRC, the underlying mechanisms are still largely unknown.
Increasing evidence has demonstrated that CRC is a heterogeneous disease, and its pathogenesis is involved with the activation of oncogenes and inactivation of tumour-suppressive genes, which are mostly resulting from genetic mutations and epigenetic alterations, the latter including DNA methylation, histone modification and noncoding RNAs (ncRNAs). [2] [3] [4] [5] [6] [7] Large-scale genome sequencing has indicated that the human genome encodes approximately 20 000 protein-coding transcripts, which account for only around 2% of the genome, while more than 90% of the total genome is actively transcribed, but lack of protein-coding potential, referred to as ncRNAs. 8, 9 For several decades, ncRNAs were considered as 'evolutionary junk'. However, more and more evidence has shown that a part of ncRNAs are functional RNA molecules. 10 These functional RNA transcripts are composed by housekeeping ncRNAs, including highly abundant ribosomal RNAs (rRNAs) and transfer RNAs (tRNAs), as well as regulatory ncRNAs, such as microRNAs (miRNAs), PIWI-interacting RNA (piRNAs), tRNA-derived small RNA (tRFs), small nucleolar RNA (snoRNAs), siRNAs, long non-coding RNAs (lncRNAs) and circular RNAs (circRNAs).
In addition, according to the length of ncRNAs, they are divided into two subclasses: small or short non-coding RNAs (sncRNAs, 18-200 nt) and lncRNAs (>200 nt).
Long non-coding RNAs are a subgroup of non-coding RNAs, with more than 200 nucleotides in length and no protein coding potential.
Long non-coding RNAs have tissue-specific expression and exert regulatory functions in many biological and pathological processes.
They can function as both tumour suppressors and promoters in CRC development. 11 For example, H19 is an imprinted oncofoetal ncRNA, but it is hypomethylated and thus up-regulated in CRC.
H19 can promote the development of CRC via generating miRNA or by serving as ceRNA. 12 Down-regulation of lncRNA MEG3 can promote colorectal adenocarcinoma cell proliferation and inhibit the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1. 13 17 In this review, we provide an overview of the representative classes of sncRNAs, including miRNAs, piRNAs and tRFs, and summarize their involvements in CRC, focusing on their roles in the initiation and development of CRC, as well as their biomarker potential (Table 1) . with cell proliferation, apoptosis, metastasis and drug resistance.
| MICRORNA S
Furthermore, aberrant miRNAs can also be used as a potential diagnostic and prognostic biomarker for cancers. 17, [23] [24] [25] [26] [27] [28] Recently, the involvement of miRNAs in the pathogenesis of CRC has been relatively clarified. which, miR-143 and miR-145 were found to be reduced in CRC tissue compared to healthy tissue. 33 In another study, Schetter et al screened 37 differentially expressed miRNAs by miRNAs microarray in 84 CRC tissues. 34 In addition, a panel of dysregulated miRNAs has been detected by Real-time PCR in CRC. Yong et al identified some differentially expressed miRNAs in both CRC tissues and blood derived from CRC patients, of which, miR-23a, miR-193a-3p and miR-338-5p were significantly up-regulated in CRC tissues, and the levels of these miRNAs are positively related between CRC tissue and blood. 35 Meanwhile, an exosomal miRNA profile was used to highlight the most abundant miRNAs in the blood of 88 patients with CRC. 36 As well as circulating miRNAs, some stool-based miRNAs were also observed to be dysregulated and they also can be used as a biomarker for CRC. For example, miR-7, miR-17, miR-20a and miR-21 are increased in the stool of CRC patients, while miR-9, miR-29b, miR-138 and miR-143 are decreased. The pre-miRNA is exported from the nucleus into the cytoplasm by Exportin-5. Then the pre-miRNA is processed by the RNase III endonuclease Dicer, yielding a miRNA-double duplex, which is loaded into Argonaute (Ago) protein to generate the RNA-induced silencing complex (RISC), then one strand of the duplex is degraded while the other guides the RISC to the target mRNA, thus leading to direct mRNA cleavage or translational repressing let-7 binding sites at their 3′ UTR. The reduction in let-7 in cancer tissues is correlated with higher KRAS mRNA expression; and let-7 miRNA suppressed colon cancer growth and proliferation. 79 miR-143 has been also shown down-regulated in CRC tissues, and reduced expression of miR-143 led to cell proliferation in vitro, which is linked to the increased expression of KRAS. 66 In contrast, miR-31 has been shown to negatively regulate KRAS inhibitor RASA1; thus, miR-31 could be a potent enhancer of KRAS in CRC. miRNAs also play important roles in regulating TGF-β signalling. 80 However, previous data have revealed that piRNAs biogenesis during adult spermatogenesis in mice is independent of the ping-pong mechanism. [88] [89] [90] ; piR-55490 inhibits lung cancer cell proliferation and the mechanism is associated with its binding to 3′ UTR of mTOR messenger RNA (mRNA). 97 piR-32051, piR-39894 and piR-43607 were found up-regulated in kidney cancer tissues. 98 PIWI-interacting RNA DQ594040 is one down-regulated piRNA in bladder cancer, and its overexpression can inhibit bladder cancer cell proliferation, colony formation and promote cell apoptosis through up-regulating TNFSF4 protein. 99 As for CRC, piR-651 was found to be up-regulated in tumour tissues, which is associated with metastasis state. piR59056, piR-54878 and piR-62701 are also highly expressed in CRC, and are associated with recurrence-free survival. 91 piR-823 contributes to colorectal tumorgenesis by enhancing the transcriptional activity of HSF1. 100 Chu et al observed that an lncRNA, LNC00964-3, which includes the piR-015551 sequence, is significantly lower in CRC tissues. Meanwhile, the expression of piR-015551 is positively correlated with LNC00964-3, indicating that piR-015551 might be generated from LNC00964-3, and may be implicated in the development of CRC. tRNA-derived fragment (tRFs), about 14-30 nt length, derived from the mature or primary tRNAs ( Figure 2 ). 107 Herein, we will focus on the roles of tRFs in the development of CRC.
tRNA-derived fragments have three subtypes: tRF-5s, tRF-3s
and inter tRFs. 109 The production of tRF-5s
and tRF-3s has reported to be dependent on Dicer. 109 However, the specific process of generating tRF-5s and tRF-3s is still not clear.
Meanwhile, the biogenesis mechanism of tRF-1s is also unknown.
Recently, tRFs have been found to play an important role in many biological and pathological processes, and they are associated with many diseases, such as virus infection, metabolic disorder, neurodegenerative diseases and cancers. 17, 109, 110 To date, the regulatory mechanisms of tRFs mainly involve several strategies as follows.
tRNA-derived fragments have also been reported to be involved 
| CON CLUS ION
Although great achievements have been made in understanding the pathogenesis of CRC, the underlying mechanisms are still needed F I G U R E 2 The types of tsRNAs are classified by size and sequence location in the tRNA structure. Based on the length and cleavage sites of tRNAs, small non-coding RNA derived from tRNAs can be classified into two major groups: tRNA-derived stress-induced RNA (tiRNAs), with the length of 28-36 nt, and tRNA-derived fragment (tRFs), about 14-30 nt length for further investigations. For decades, many studies have provided a lot of evidence that sncRNAs are important regulatory molecules and play a crucial role in cancer development and progression. So, it is believed that sncRNAs are involved in the pathogenesis of CRC.
Notably, many miRNAs have been demonstrated to be dysregulated in CRC, and they may exert important functions in the development of CRC. Furthermore, they have been found to act as potential diagnostic biomarkers for CRC. In addition, some piRNAs and tRFs have also been proven to be implicated in the development of CRC.
However, studies on them are still at a very early stage, and many questions still need to be addressed. In conclusion, considering sncRNAs as important regulators in CRC, we need to shed light on many aspects of their biogenesis and functions in CRC.
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